(Q45837672)

16 December 2017

title

Protection of cottontop tamarins against Epstein-Barr virus-induced malignant lymphoma by a prototype subunit vaccine (English)

1 reference

16 December 2017

0 references

0 references

Epstein MA

1

1 reference

16 December 2017

Morgan AJ

2

1 reference

16 December 2017

Finerty S

3

1 reference

16 December 2017

Randle BJ

4

1 reference

16 December 2017

Kirkwood JK

5

1 reference

16 December 2017

language of work or name

English

0 references

publication date

1 November 1985

1 reference

16 December 2017

published in

Nature

1 reference

16 December 2017

volume

318

1 reference

16 December 2017

issue

6043

1 reference

16 December 2017

page(s)

287-289

1 reference

16 December 2017

Epstein-Barr Virus — Is It Time To Develop a Vaccine Program?

cites work

1 reference

7 January 2021

Appearance of Epstein-Barr virus-associated antigens in infected Raji cells

1 reference

7 January 2021

Comparison of EBV neutralization tests based on abortive infection or transformation of lymphoid cells and their relation to membrane reactive antibodies (anti-MA).

1 reference

7 January 2021

Alterations of the immunological specificity of plasma membranes from cells infected with Marek's disease and turkey herpes viruses

1 reference

7 January 2021

Immunization against Marek's disease using Marek's disease virus-specific antigens free from infectious virus

1 reference

7 January 2021

A highly sensitive enzyme-linked immunosorbent assay to quantitate antibodies to Epstein-Barr virus membrane antigen gp340.

1 reference

7 January 2021

Individual tumors of multifocal EB virus-induced malignant lymphomas in tamarins arise from different B-cell clones

1 reference

7 January 2021

Factors influencing population growth of a colony of cotton-top tamarins

1 reference

7 January 2021

Quantification of an Epstein-Barr virus-associated membrane antigen component

1 reference

7 January 2021

Effect of the diterpene ester TPA on Epstein-Barr virus antigen- and DNA synthesis in producer and nonproducer cell lines

1 reference

7 January 2021

Assay of the infectivity of Epstein-Barr virus by transformation of human leucocytes in vitro

1 reference

7 January 2021

Purification and Properties of the gp340 Component of Epstein--Barr Virus Membrane Antigen in an Immunogenic Form

1 reference

7 January 2021

Purified Epstein-Barr virus Mr 340,000 glycoprotein induces potent virus-neutralizing antibodies when incorporated in liposomes

1 reference

7 January 2021

Comparative immunogenicity studies on epstein-barr virus membrane antigen (MA) gp340 with novel adjuvants in mice, rabbits, and cotton-top tamarins

1 reference

7 January 2021

A structural investigation of the Epstein-Barr (EB) virus membrane antigen glycoprotein, gp340.

1 reference

7 January 2021

An Epstein-Barr virus DNA fragment encodes messages for the two major envelope glycoproteins (gp350/300 and gp220/200)

1 reference

7 January 2021

Transcription and DNA sequence of the BamHI L fragment of B95-8 Epstein-Barr virus.

1 reference

7 January 2021

Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped viruses.

1 reference

7 January 2021

Infectious vaccinia virus recombinants that express hepatitis B virus surface antigen

1 reference

7 January 2021

Live recombinant vaccinia virus protects chimpanzees against hepatitis B.

1 reference

7 January 2021

Vaccinia virus recombinants: expression of VSV genes and protective immunization of mice and cattle

1 reference

7 January 2021

Identifiers

DOI

10.1038/318287A0

1 reference

16 December 2017

Dimensions Publication ID

1033348839

0 references

Fatcat ID

release_nvyth72b4zggvivdy5a7lbdv4q

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/nvyth72b4zggvivdy5a7lbdv4q

24 November 2022

mapped directly with Wikidata item

1 reference

16 December 2017